R. E. Y. de Goede - Concepedia

Concepedia

Author

R. E. Y. de Goede

Dutch Blood Transfusion Society

Also Known As

R E Y De Goede, R. E. Y. DE GOEDE, R. E. Y. De Goede, R. E. Y. de Goede, R.E.Y. De Goede, R.E.Y. de Goede, R. E. Y. de Goede, RUUD E.Y. DE GOEDE, RUUD E.Y. de GOEDE, Ruud E Y de Goede

22

Publications

1.8K

Citations

15

H-Index

39

Concepts

All Affiliations

Dutch Blood Transfusion Society University of Amsterdam GGD Amsterdam Amsterdam UMC Location University of Amsterdam The Netherlands Cancer Institute

RE

About

R. E. Y. de Goede is an author at Dutch Blood Transfusion Society specializing in medicine, hiv, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1K
2	Natural Sciences	2	2	91
3	Biochemistry	2	2	645
4	Cell Biology	2	2	75
5	Social Sciences	1	1	11

R. E. Y. de Goede

×

16

Publications

1.8K

Citations

15

H-Index

	Year	Citations
Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase Rob A. Gruters, Jacques Neefjes, Matthijs Tersmette, Nature BiochemistryMedicineHuman RetrovirusGlycobiologyAntiviral Drug Development	1987	578
HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay Maarten Koot, A.H.V. Vos, René Keet, AIDS	1992	350
Zidovudine sensitivity of human immunodeficiency viruses from high-risk, symptom-free individuals during therapy Charles A. Boucher, J Lange, Jaap Goudsmit, The Lancet Primary ImmunodeficiencyHuman RetrovirusHuman Immunodeficiency VirusesImmunologyAntiviral Therapy	1990	179
Relation between Changes in Cellular Load, Evolution of Viral Phenotype, and the Clonal Composition of Virus Populations in the Course of Human Immunodeficiency Virus Type 1 Infection M. Koot, Angélique B. van ’t Wout, Neeltje A. Kootstra, The Journal of Infectious Diseases	1996	144
Conversion Rate towards a Syncytium‐Inducing (SI) Phenotype during Different Stages of Human Immunodeficiency Virus Type 1 Infection and Prognostic Value of SI Phenotype for Survival after AIDS Diagnosis M. Koot, Remko van Leeuwen, R. E. Y. de Goede, The Journal of Infectious Diseases	1999	105
Immunological and virological markers in individuals progressing from seroconversion to AIDS Rob A. Gruters, Fokke G. Terpstra, R. E. Y. de Goede, AIDS	1991	86
Chemical modification of azasugars, inhibitors of N‐glycoprotein‐processing glycosidases and of HIV‐I infection: Review and structure‐activity relationships Leon A. G. M. van den Broek, D. J. Vermaas, B. M. Heskamp, Recueil des Travaux Chimiques des Pays-Bas Dmm AnaloguesGlycobiologyChemical ModificationAntiviral DrugN‐glycoprotein‐processing Glycosidases	1993	67
Cytotoxic Activity of Human Lymphocytes: Quantitative Analysis of T Cell and K Cell Cytotoxicity, Revealing Enzyme-Like Kinetics Wim P. Zeijlemaker, Rien H. J. van Oers, R. E. Y. de Goede, The Journal of Immunology	1977	56
Human immunodeficiency virus infection studied in CD4-expressing human-murine T-cell hybrids M Tersmette, Jacques J. M. van Dongen, Paul R. Clapham, Virology Primary ImmunodeficiencyHuman RetrovirusImmunologyAntiviral ResponseVirology	1989	52
Differential Tropism of Clinical HIV-1 Isolates for Primary Monocytes and Promonocytic Cell Lines Hanneke Schuitemaker, Neeltje A. Kootstra, M Groenink, AIDS Research and Human Retroviruses ImmunologyViral DynamicHiv-1 IsolatesImmunotherapyPrimary Monocyte-derived Macrophages	1992	29

Page 1